Cargando…
Cholesterol availability modulates myoblast fusion
The requirement of cholesterol for myoblast fusion has been linked to the primary step in the fusion process, calcium-dependent aggregation (recognition). Inhibition of cholesterol synthesis with 25- hydroxycholesterol or compactin in the absence of exogenous lipid dramatically inhibits calcium-medi...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1980
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2110695/ https://www.ncbi.nlm.nih.gov/pubmed/7410480 |
_version_ | 1782139645073555456 |
---|---|
collection | PubMed |
description | The requirement of cholesterol for myoblast fusion has been linked to the primary step in the fusion process, calcium-dependent aggregation (recognition). Inhibition of cholesterol synthesis with 25- hydroxycholesterol or compactin in the absence of exogenous lipid dramatically inhibits calcium-mediated aggregation and concomitant fusion within several hours. Restimulating cholesterol synthesis or supplying exogenous cholesterol rapidly restores aggregation activity. Over this time period, however, the sterol:phospholipid ratio is unaltered, suggesting a local rather than a general membrane cholesterol requirement for the expression of aggregation activity. The aggregation response to a change in sterol availability occurs on a shorter time scale than that required to inhibit the synthesis of the protein(s) with aggregation activity; thus, the cholesterol-requiring step is posttranslational. We suggest that the assembly or maintenance of the aggregation activity depends on a continued local supply of cholesterol. |
format | Text |
id | pubmed-2110695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1980 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21106952008-05-01 Cholesterol availability modulates myoblast fusion J Cell Biol Articles The requirement of cholesterol for myoblast fusion has been linked to the primary step in the fusion process, calcium-dependent aggregation (recognition). Inhibition of cholesterol synthesis with 25- hydroxycholesterol or compactin in the absence of exogenous lipid dramatically inhibits calcium-mediated aggregation and concomitant fusion within several hours. Restimulating cholesterol synthesis or supplying exogenous cholesterol rapidly restores aggregation activity. Over this time period, however, the sterol:phospholipid ratio is unaltered, suggesting a local rather than a general membrane cholesterol requirement for the expression of aggregation activity. The aggregation response to a change in sterol availability occurs on a shorter time scale than that required to inhibit the synthesis of the protein(s) with aggregation activity; thus, the cholesterol-requiring step is posttranslational. We suggest that the assembly or maintenance of the aggregation activity depends on a continued local supply of cholesterol. The Rockefeller University Press 1980-09-01 /pmc/articles/PMC2110695/ /pubmed/7410480 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Cholesterol availability modulates myoblast fusion |
title | Cholesterol availability modulates myoblast fusion |
title_full | Cholesterol availability modulates myoblast fusion |
title_fullStr | Cholesterol availability modulates myoblast fusion |
title_full_unstemmed | Cholesterol availability modulates myoblast fusion |
title_short | Cholesterol availability modulates myoblast fusion |
title_sort | cholesterol availability modulates myoblast fusion |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2110695/ https://www.ncbi.nlm.nih.gov/pubmed/7410480 |